Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 6
2014 5
2015 2
2016 1
2017 3
2018 3
2019 10
2020 12
2021 12
2022 10
2023 16
2024 8
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
Vaidya JS, Bulsara M, Baum M, Wenz F, Massarut S, Pigorsch S, Alvarado M, Douek M, Saunders C, Flyger HL, Eiermann W, Brew-Graves C, Williams NR, Potyka I, Roberts N, Bernstein M, Brown D, Sperk E, Laws S, Sütterlin M, Corica T, Lundgren S, Holmes D, Vinante L, Bozza F, Pazos M, Le Blanc-Onfroy M, Gruber G, Polkowski W, Dedes KJ, Niewald M, Blohmer J, McCready D, Hoefer R, Kelemen P, Petralia G, Falzon M, Joseph DJ, Tobias JS. Vaidya JS, et al. Among authors: sperk e. BMJ. 2020 Aug 19;370:m2836. doi: 10.1136/bmj.m2836. BMJ. 2020. PMID: 32816842 Free PMC article. Clinical Trial.
Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types.
Naderi E, Aguado-Barrera ME, Schack LMH, Dorling L, Rattay T, Fachal L, Summersgill H, Martínez-Calvo L, Welsh C, Dudding T, Odding Y, Varela-Pazos A, Jena R, Thomson DJ, Steenbakkers RJHM, Dennis J, Lobato-Busto R, Alsner J, Ness A, Nutting C, Gómez-Caamaño A, Eriksen JG, Thomas SJ, Bates AM, Webb AJ, Choudhury A, Rosenstein BS, Taboada-Valladares B, Herskind C, Azria D, Dearnaley DP, de Ruysscher D, Sperk E, Hall E, Stobart H, Chang-Claude J, De Ruyck K, Veldeman L, Altabas M, De Santis MC, Farcy-Jacquet MP, Veldwijk MR, Sydes MR, Parliament M, Usmani N, Burnet NG, Seibold P, Symonds RP, Elliott RM, Bultijnck R, Gutiérrez-Enríquez S, Mollà M, Gulliford SL, Green S, Rancati T, Reyes V, Carballo A, Peleteiro P, Sosa-Fajardo P, Parker C, Fonteyne V, Johnson K, Lambrecht M, Vanneste B, Valdagni R, Giraldo A, Ramos M, Diergaarde B, Liu G, Leal SM, Chua MLK, Pring M, Overgaard J, Cascallar-Caneda LM, Duprez F, Talbot CJ, Barnett GC, Dunning AM, Vega A, Andreassen CN, Langendijk JA, West CML, Alizadeh BZ, Kerns SL; Radiogenomics Consortium. Naderi E, et al. Among authors: sperk e. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad088. doi: 10.1093/jncics/pkad088. JNCI Cancer Spectr. 2023. PMID: 37862240 Free PMC article.
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial.
Giordano FA, Layer JP, Leonardelli S, Friker LL, Turiello R, Corvino D, Zeyen T, Schaub C, Müller W, Sperk E, Schmeel LC, Sahm K, Oster C, Kebir S, Hambsch P, Pietsch T, Bisdas S, Platten M, Glas M, Seidel C, Herrlinger U, Hölzel M. Giordano FA, et al. Among authors: sperk e. Nat Commun. 2024 May 28;15(1):4210. doi: 10.1038/s41467-024-48416-9. Nat Commun. 2024. PMID: 38806504 Free PMC article. Clinical Trial.
In Reply to Ward et al.
Vaidya JS, Bulsara M, Wenz F, Sperk E, Massarut S, Alvarado M, Williams NR, Brew-Graves C, Bernstein M, Holmes D, Vinante L, Pigorsch S, Lundgren S, Uhl V, Joseph D, Tobias JS. Vaidya JS, et al. Among authors: sperk e. Int J Radiat Oncol Biol Phys. 2023 Jan 1;115(1):256-259. doi: 10.1016/j.ijrobp.2022.10.009. Int J Radiat Oncol Biol Phys. 2023. PMID: 36526392 No abstract available.
In Regard to Polgar et al.
Vaidya JS, Bulsara M, Sperk E, Massarut S, Douek M, Alvarado M, Pigorsch S, Holmes D, Bernstein M, Saunders C, Flyger H, Joseph D, Wenz F, Tobias JS; TARGIT-A Investigators. Vaidya JS, et al. Among authors: sperk e. Int J Radiat Oncol Biol Phys. 2021 Jul 1;110(3):905-907. doi: 10.1016/j.ijrobp.2021.01.059. Epub 2021 Feb 25. Int J Radiat Oncol Biol Phys. 2021. PMID: 33640419 No abstract available.
The TARGIT-A Randomized Trial: TARGIT-IORT Versus Whole Breast Radiation Therapy: Long-Term Local Control and Survival.
Vaidya JS, Bulsara M, Wenz F, Sperk E, Massarut S, Alvarado M, Williams NR, Brew-Graves C, Bernstein M, Holmes D, Vinante L, Pigorsch S, Lundgren S, Uhl V, Joseph D, Tobias JS; TARGIT-A authors. Vaidya JS, et al. Among authors: sperk e. Int J Radiat Oncol Biol Phys. 2023 Jan 1;115(1):77-82. doi: 10.1016/j.ijrobp.2022.08.029. Epub 2022 Aug 23. Int J Radiat Oncol Biol Phys. 2023. PMID: 35998867 Free article. No abstract available.
Accelerated Partial Breast Irradiation in Clinical Practice.
Wenz F, Sedlmayer F, Herskind C, Welzel G, Sperk E, Neumaier C, Gauter-Fleckenstein B, Vaidya JS, Sütterlin M. Wenz F, et al. Among authors: sperk e. Breast Care (Basel). 2015 Aug;10(4):247-52. doi: 10.1159/000437194. Epub 2015 Jul 15. Breast Care (Basel). 2015. PMID: 26600760 Free PMC article. Review.
Intraoperative radiotherapy (IORT) as boost in breast cancer.
Sedlmayer F, Reitsamer R, Wenz F, Sperk E, Fussl C, Kaiser J, Ziegler I, Zehentmayr F, Deutschmann H, Kopp P, Fastner G. Sedlmayer F, et al. Among authors: sperk e. Radiat Oncol. 2017 Jan 19;12(1):23. doi: 10.1186/s13014-016-0749-9. Radiat Oncol. 2017. PMID: 28103903 Free PMC article. Review.
Professional-patient discrepancies in assessing lung cancer radiotherapy symptoms: An international multicentre study.
Aguado-Barrera ME, Lopez-Pleguezuelos C, Gómez-Caamaño A, Calvo-Crespo P, Taboada-Valladares B, Azria D, Boisselier P, Briers E, Chan C, Chang-Claude J, Coedo-Costa C, Crujeiras-González A, Cuaron JJ, Defraene G, Elliott RM, Faivre-Finn C, Franceschini M, Fuentes-Rios O, Galego-Carro J, Gutiérrez-Enríquez S, Heumann P, Higginson DS, Johnson K, Lambrecht M, Lang P, Lievens Y, Mollà M, Ramos M, Rancati T, Rattay T, Rimner A, Rosenstein BS, Sangalli C, Seibold P, Sperk E, Stobart H, Symonds P, Talbot CJ, Vandecasteele K, Veldeman L, Ward T, Webb A, Woolf D, de Ruysscher D, West CML, Vega A; REQUITE Consortium. Aguado-Barrera ME, et al. Among authors: sperk e. Lung Cancer. 2025 Jan;199:108072. doi: 10.1016/j.lungcan.2024.108072. Epub 2024 Dec 27. Lung Cancer. 2025. PMID: 39740425
A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer.
Farazi M, Yang X, Gehl CJ, Barnett GC, Burnet NG, Chang-Claude J, Parker CC, Dunning AM, Azria D, Choudhury A, Rancati T, De Ruysscher D, Seibold P, Sperk E, Talbot CJ, Veldeman L, Webb AJ, Elliott R, Aguado-Barrera ME, Carballo AM, Fuentes-Ríos O, Gómez-Caamaño A, Peleteiro P, Vega A, Ostrer H, Rosenstein BS, Saito S, Parliament M, Usmani N, Marples B, Chen Y, Morrow G, Messing E, Janelsins MC, Hall W, West CML, Auer PL, Kerns SL. Farazi M, et al. Among authors: sperk e. Cancer Epidemiol Biomarkers Prev. 2025 May 2;34(5):795-804. doi: 10.1158/1055-9965.EPI-24-1228. Cancer Epidemiol Biomarkers Prev. 2025. PMID: 40029246
88 results